Initial human experience with MK-462 (rizatriptan): a novel 5-HT1D agonist.
Sciberras DG, Polvino WJ, Gertz BJ, Cheng H, Stepanavage M, Wittreich J, Olah T, Edwards M, Mant T.
Sciberras DG, et al. Among authors: wittreich j.
Br J Clin Pharmacol. 1997 Jan;43(1):49-54. doi: 10.1111/j.1365-2125.1997.tb00032.x.
Br J Clin Pharmacol. 1997.
PMID: 9056052
Free article.
Clinical Trial.